compound semaglutide ending FDA Ends Compounded GLP-1s: What to Know FDA Warns on Certain Forms

In SURPASS-5, Mounjaro lowered patient weight by 12 pounds (5 mg), 17 pounds (10 mg), and 19 pounds (15 mg) compared to a gain of 4 pounds with placebo 1

With the rapid growth of patients taking glucagon-like peptide-1 receptor agonists (GLP-1), anesthesia professionals and surgical teams are dealing with the quandary of whether to hold or not hold these medications prior to an anesthetic and surgical procedure

A step up from your basic vanilla shake: Average mouthfeel score: 3/5 | Average texture/consistency score: 3/5 | Average flavor score: 3.13/5 | Overall average score: 3.04/5 This plant-based, coconut milk shake held its own in the regular vanilla round

Regular assessments can help decide whether to continue, adjust, or discontinue the supplementation